Laurion Capital Management LP
Position in AARD — Aardvark Therapeutics, Inc.
CIK 1390202
NEW YORK, NY
Position in AARD
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$5,958,483
+$2,058,573 QoQ
Shares Held
1,034,459
0.0% QoQ
Ownership
4.73%
of shares outstanding
% of Portfolio
0.45%
of 13F equity value
Holder Rank
#3
of 72 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AARD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Laurion Capital Management LP holds $278,142,488 across 19 Biotechnology names. AARD ranks #7 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BBIO |
BridgeBio Pharma, Inc.
|
1,352,234 | $100,714,388 | |
| 2 | MLYS |
Mineralys Therapeutics, Inc.
|
2,506,152 | $67,615,980 | |
| 3 | NUVB |
Nuvation Bio Inc.
|
7,820,013 | $44,417,673 | |
| 4 | BBOT |
BridgeBio Oncology Therapeutics, Inc.
|
2,002,701 | $15,260,581 | |
| 5 | PYXS |
Pyxis Oncology, Inc.
|
4,900,888 | $14,751,672 | |
| 6 | IMUX |
Immunic, Inc.
|
610,326 | $9,380,710 | |
| 7 | AARD |
Aardvark Therapeutics, Inc.
This page
|
1,034,459 | $5,958,483 | |
| 8 | AUTL |
Autolus Therapeutics plc
|
3,316,626 | $5,306,601 |
All Filings in AARD
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,958,483 | 1,034,459 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $3,899,910 | 1,034,459 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $13,320,706 | 1,014,911 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $13,950,792 | 1,049,721 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $13,372,199 | 989,068 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $6,069,904 | 808,243 | Shares | Sole | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||